The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.

OBJECTIVES: These guidelines are based on a first edition that was published in 2002, and have been edited and updated with the available scientific evidence until September 2009. Their purpose is to supply a systematic overview of all scientific evidence pertaining to the treatment of acute bipola...

Full description

Bibliographic Details
Main Authors: Grunze, H, Vieta, E, Goodwin, G, Bowden, C, Licht, R, Möller, H, Kasper, S
Format: Journal article
Language:English
Published: 2010
_version_ 1826273667174105088
author Grunze, H
Vieta, E
Goodwin, G
Bowden, C
Licht, R
Möller, H
Kasper, S
author_facet Grunze, H
Vieta, E
Goodwin, G
Bowden, C
Licht, R
Möller, H
Kasper, S
author_sort Grunze, H
collection OXFORD
description OBJECTIVES: These guidelines are based on a first edition that was published in 2002, and have been edited and updated with the available scientific evidence until September 2009. Their purpose is to supply a systematic overview of all scientific evidence pertaining to the treatment of acute bipolar depression in adults. METHODS: The data used for these guidelines have been extracted from a MEDLINE and EMBASE search, from the clinical trial database clinicaltrials.gov, from recent proceedings of key conferences, and from various national and international treatment guidelines. Their scientific rigor was categorised into six levels of evidence (A-F). As these guidelines are intended for clinical use, the scientific evidence was finally assigned different grades of recommendation to ensure practicability. RESULTS: We identified 10 pharmacological monotherapies or combination treatments with at least limited positive evidence for efficacy in bipolar depression, several of them still experimental and backed up only by a single study. Only one medication was considered to be sufficiently studied to merit full positive evidence. CONCLUSIONS: Although major advances have been made since the first edition of this guideline in 2002, there are many areas which still need more intense research to optimize treatment. The majority of treatment recommendations is still based on limited data and leaves considerable areas of uncertainty.
first_indexed 2024-03-06T22:31:42Z
format Journal article
id oxford-uuid:587f5b10-161f-4383-b430-a1b423aef8a5
institution University of Oxford
language English
last_indexed 2024-03-06T22:31:42Z
publishDate 2010
record_format dspace
spelling oxford-uuid:587f5b10-161f-4383-b430-a1b423aef8a52022-03-26T17:03:51ZThe World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:587f5b10-161f-4383-b430-a1b423aef8a5EnglishSymplectic Elements at Oxford2010Grunze, HVieta, EGoodwin, GBowden, CLicht, RMöller, HKasper, S OBJECTIVES: These guidelines are based on a first edition that was published in 2002, and have been edited and updated with the available scientific evidence until September 2009. Their purpose is to supply a systematic overview of all scientific evidence pertaining to the treatment of acute bipolar depression in adults. METHODS: The data used for these guidelines have been extracted from a MEDLINE and EMBASE search, from the clinical trial database clinicaltrials.gov, from recent proceedings of key conferences, and from various national and international treatment guidelines. Their scientific rigor was categorised into six levels of evidence (A-F). As these guidelines are intended for clinical use, the scientific evidence was finally assigned different grades of recommendation to ensure practicability. RESULTS: We identified 10 pharmacological monotherapies or combination treatments with at least limited positive evidence for efficacy in bipolar depression, several of them still experimental and backed up only by a single study. Only one medication was considered to be sufficiently studied to merit full positive evidence. CONCLUSIONS: Although major advances have been made since the first edition of this guideline in 2002, there are many areas which still need more intense research to optimize treatment. The majority of treatment recommendations is still based on limited data and leaves considerable areas of uncertainty.
spellingShingle Grunze, H
Vieta, E
Goodwin, G
Bowden, C
Licht, R
Möller, H
Kasper, S
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
title The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
title_full The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
title_fullStr The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
title_full_unstemmed The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
title_short The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
title_sort world federation of societies of biological psychiatry wfsbp guidelines for the biological treatment of bipolar disorders update 2010 on the treatment of acute bipolar depression
work_keys_str_mv AT grunzeh theworldfederationofsocietiesofbiologicalpsychiatrywfsbpguidelinesforthebiologicaltreatmentofbipolardisordersupdate2010onthetreatmentofacutebipolardepression
AT vietae theworldfederationofsocietiesofbiologicalpsychiatrywfsbpguidelinesforthebiologicaltreatmentofbipolardisordersupdate2010onthetreatmentofacutebipolardepression
AT goodwing theworldfederationofsocietiesofbiologicalpsychiatrywfsbpguidelinesforthebiologicaltreatmentofbipolardisordersupdate2010onthetreatmentofacutebipolardepression
AT bowdenc theworldfederationofsocietiesofbiologicalpsychiatrywfsbpguidelinesforthebiologicaltreatmentofbipolardisordersupdate2010onthetreatmentofacutebipolardepression
AT lichtr theworldfederationofsocietiesofbiologicalpsychiatrywfsbpguidelinesforthebiologicaltreatmentofbipolardisordersupdate2010onthetreatmentofacutebipolardepression
AT mollerh theworldfederationofsocietiesofbiologicalpsychiatrywfsbpguidelinesforthebiologicaltreatmentofbipolardisordersupdate2010onthetreatmentofacutebipolardepression
AT kaspers theworldfederationofsocietiesofbiologicalpsychiatrywfsbpguidelinesforthebiologicaltreatmentofbipolardisordersupdate2010onthetreatmentofacutebipolardepression
AT grunzeh worldfederationofsocietiesofbiologicalpsychiatrywfsbpguidelinesforthebiologicaltreatmentofbipolardisordersupdate2010onthetreatmentofacutebipolardepression
AT vietae worldfederationofsocietiesofbiologicalpsychiatrywfsbpguidelinesforthebiologicaltreatmentofbipolardisordersupdate2010onthetreatmentofacutebipolardepression
AT goodwing worldfederationofsocietiesofbiologicalpsychiatrywfsbpguidelinesforthebiologicaltreatmentofbipolardisordersupdate2010onthetreatmentofacutebipolardepression
AT bowdenc worldfederationofsocietiesofbiologicalpsychiatrywfsbpguidelinesforthebiologicaltreatmentofbipolardisordersupdate2010onthetreatmentofacutebipolardepression
AT lichtr worldfederationofsocietiesofbiologicalpsychiatrywfsbpguidelinesforthebiologicaltreatmentofbipolardisordersupdate2010onthetreatmentofacutebipolardepression
AT mollerh worldfederationofsocietiesofbiologicalpsychiatrywfsbpguidelinesforthebiologicaltreatmentofbipolardisordersupdate2010onthetreatmentofacutebipolardepression
AT kaspers worldfederationofsocietiesofbiologicalpsychiatrywfsbpguidelinesforthebiologicaltreatmentofbipolardisordersupdate2010onthetreatmentofacutebipolardepression